Selected article for: "cerebrospinal fluid and public health"
Author: Romero, Alejandro; Ramos, Eva; López-Muñoz, Francisco; Gil-Martín, Emilio; Escames, Germaine; Reiter, Russel J.
Title: Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
  • Cord-id: 4ifwiisy
  • Document date: 2020_8_9
    • ID: 4ifwiisy
    Snippet: The world faces an exceptional new public health concern caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), subsequently termed the coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO). Although the clinical symptoms mostly have been characterized, the scientific community still doesn´t know how SARS-CoV-2 successfully reaches and spreads throughout the central nervous system (CNS) inducing brain damage. The recent detection of SARS-CoV-2 in the ce
    Document: The world faces an exceptional new public health concern caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), subsequently termed the coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO). Although the clinical symptoms mostly have been characterized, the scientific community still doesn´t know how SARS-CoV-2 successfully reaches and spreads throughout the central nervous system (CNS) inducing brain damage. The recent detection of SARS-CoV-2 in the cerebrospinal fluid (CSF) and in frontal lobe sections from postmortem examination has confirmed the presence of the virus in neural tissue. This finding reveals a new direction in the search for a neurotherapeutic strategy in the COVID-19 patients with underlying diseases. Here, we discuss the COVID-19 outbreak in a neuroinvasiveness context and suggest the therapeutic use of high doses of melatonin, which may favorably modulate the immune response and neuroinflammation caused by SARS-CoV-2. However, clinical trials elucidating the efficacy of melatonin in the prevention and clinical management in the COVID-19 patients should be actively encouraged.

    Search related documents:
    Co phrase search for related documents
    • acetylcholine nicotinic receptor and acute ards respiratory distress syndrome: 1
    • acetylcholine receptor and acute ali lung injury: 1, 2
    • acetylcholine receptor and acute ards respiratory distress syndrome: 1, 2
    • acute ali lung injury and adjuvant treatment: 1, 2
    • acute ali lung injury and administration route: 1, 2
    • acute ards respiratory distress syndrome and adjuvant treatment: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and administration impact: 1, 2, 3
    • acute ards respiratory distress syndrome and administration route: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory infectious disease and administration route: 1
    • adjuvant treatment and administration route: 1